Pharmafile Logo
Pharmafocus logo
Advanced Search
Lyrica image

Blow for Pfizer as Lyrica misses target

March 13, 2015
Sales and Marketing FDA, Lyrica, Pfizer, fibromyalgia, pain, pregablin

A late-stage study of Pfizer’s Lyrica has failed to demonstrate it has any significant pain reduction in patients with fibromyalgia. …

News
GSK image

GSK sells off stake in Aspen for $853m

March 13, 2015
Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern

GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …

News
Takeda HQ, Tokyo image

Takeda gets NICE nod for bowel treatment

March 13, 2015
Sales and Marketing NHS, NICE, Takeda, enyyvio, vedolizumab

Takeda’s Entyvio becomes the first NICE approved gut-selective treatment for UK patients with ulcerative colitis (UC) – a long-term condition …

News
samantha_treadwell

AXON Communications adds five to London team

March 13, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Axon, bilotta, burns, peregrin, treadwell, ura

UK healthcare comms and PR firm AXON Communications has added five new members to its team in London. Lucie Burns …

Appointment
J&J image

J&J pleads guilty over children’s contaminated medicine

March 12, 2015
Manufacturing and Production, Sales and Marketing FDA, J&J, JJ, McNeil, OTC, Tylenol, consta, hamburg, recall

Johnson & Johnson’s consumer division McNeil has pleaded guilty and will pay fines of $25 million for wrongdoings regarding its …

News

NHS backtracks on Cancer Drugs Fund de-listings

March 12, 2015
Sales and Marketing Afinitor, CDF, Cancer Drugs Fund, England, Halaven, NHS, Novartis, everolimus

NHS England is expected to perform a U-turn on several decisions to remove treatments from the cancer drugs fund when …

News
Salix image

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015
Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …

News
GSK image

GSK picks Singapore for Asian hub

March 12, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets

Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …

News

UCB sponsors ‘Hack Epilepsy’ digital event

March 12, 2015
Medical Communications, Sales and Marketing Keppra, UCB, epilepsy, hack, lacosamide, levetiracetam, vimpat

Belgian biopharma firm UCB says it will be sponsoring a ‘Hack Epilepsy’ event this year to help support patient needs …

News
larry_alleva

Adaptimmune appoints PwC head to board

March 12, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lawrence Alleva, adaptimune, pwC

Clinical-stage biotech firm Adaptimmune has appointed Lawrence Alleva as a non-executive director who is also to serve as chairman of its …

Appointment
Keytruda image

Merck’s cancer drug sees first ever early access nod

March 11, 2015
Sales and Marketing Cancer, ICR, Merck, eams, early access, keytruda, melanoma, oncology, pembrolizumab

Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …

News
Merck Serono image

Merck Serono bets on precision medicine

March 11, 2015
Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised

Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …

News
GSK image

GSK China scandal leads to staff conflict

March 11, 2015
Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked

Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …

News
NHS image

Government pledges ‘new era’ for NHS

March 11, 2015
Research and Development, Sales and Marketing NHS, Simon Stevens, five year, reform, reorganisation, vanguard

The government is investing £200 million to back healthcare professionals to implement their own ideas for improving patient care. The …

News

New details of Innovative Medicines review disclosed

March 11, 2015
Research and Development, Sales and Marketing ABPI, NHS, NICE, PPRS, UK, george freeman, innovative medicines

The government has announced details of a sweeping review into how medicines are accessed in the UK. The Innovative Medicines …

News

NICE approves Roche’s Gazyvaro and Novartis’ Xolair

March 11, 2015
Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab

NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …

News
tom_griffiths_virgo

New head of digital for Virgo Health

March 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, tom griffiths

UK-based healthcare comms agency Virgo Health has increased its leadership team through the appointment of Tom Griffiths as head of digital.  …

Appointment

HRT pills linked to increase in clots and strokes

March 10, 2015
Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy

HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …

News
Lilly image

German court rules against Lilly in Alimta patent case

March 10, 2015
Manufacturing and Production, Sales and Marketing ACS, Actavis, Alimta, NICE, NSCLC, lilly, lung cancer, pemetrexed

A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …

News
Sovaldi image

$10 generic Solvaldi emerges in Bangladesh

March 10, 2015
Manufacturing and Production, Sales and Marketing Gilead, World Trade Organization, hep C, incepta, sofosbuvir, sofosbuvir), sovaldi

A Bangladeshi pharma company is producing an unlicensed generic version of Gilead’s hepatitis C drug Sovaldi for $10 per pill …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026